Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ANTARES PHARMA, INC.

(ATRS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 429767665602--
Entreprise Value (EV)1 429767665602602602
P/E ratio -68,0x-470x12,1x34,9x16,7x10,3x
Yield ------
Capitalization / Revenue 6,74x6,19x4,45x3,22x2,59x2,23x
EV / Revenue 6,74x6,19x4,45x3,22x2,59x2,23x
EV / EBITDA ---22,9x11,2x7,55x
Price to Book ------
Nbr of stocks (in thousands) 157 541163 226166 672169 968--
Reference price (USD) 2,724,703,993,543,543,54
Announcement Date 02/28/201903/03/202003/02/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 63,6124150187232270
EBITDA1 ---26,353,779,7
Operating profit (EBIT)1 -16,60,9913,625,848,777,0
Operating Margin -26,1%0,80%9,10%13,8%21,0%28,5%
Pre-Tax Profit (EBT)1 -6,52-2,039,9222,047,277,3
Net income1 -6,52-2,0356,217,638,060,3
Net margin -10,3%-1,64%37,6%9,41%16,3%22,3%
EPS2 -0,04-0,010,330,100,210,35
Dividend per Share ------
Announcement Date 02/28/201903/03/202003/02/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1
Net sales1 44,142,145,048,851,250,3
EBITDA1 --7,716,306,00-
Operating profit (EBIT)1 6,105,396,796,596,977,63
Operating Margin 13,8%12,8%15,1%13,5%13,6%15,1%
Pre-Tax Profit (EBT)1 5,114,385,565,796,206,83
Net income1 51,43,794,424,544,845,11
Net margin 116%9,01%9,83%9,30%9,46%10,2%
EPS2 0,300,020,030,030,030,03
Dividend per Share ------
Announcement Date 03/02/202105/06/202108/05/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt ------
Net Cash position ------
Leverage (Debt / EBITDA) ------
Free Cash Flow1 -18,2-13,011,726,247,865,6
ROE (Net Profit / Equities) ------
Shareholders' equity1 ------
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share ------
Cash Flow per Share ------
Capex1 0,852,359,624,505,805,93
Capex / Sales 1,34%1,90%6,43%2,40%2,50%2,20%
Announcement Date 02/28/201903/03/202003/02/2021---
1 USD in Million
Key data
Capitalization (USD) 601 685 438
Net sales (USD) 149 599 000
Number of employees 185
Sales / Employee (USD) 808 643
Free-Float 97,9%
Free-Float capitalization (USD) 588 750 402
Avg. Exchange 20 sessions (USD) 2 008 761
Average Daily Capital Traded 0,33%
EPS & Dividend
Year-on-year evolution of the PER